Trending Now
Commercial

Litigation Funding in Brazil Could Explode After 231,000 Patents Are Granted to Reduce Backlog

January 15, 2018

Litigation Funding in Brazil Could Explode After 231,000 Patents Are Granted to Reduce Backlog

For the past 15 years, Brazil has suffered one of the world’s most chronic and severe backlogs of pending patents. Now, the Brazilian Patent and Trademark Office (PTO), is looking to reduce that backlog in one fell swoop: by granting patent rights until 2020 to 231,000 pending applications with no examination. The Brazilian government is seeking to introduce this emergency measure as an “extraordinary solution” to the crisis that has plagued the nation’s patent market for a generation. Brazil’s patent problems arose after it enacted the Patent Statute in 1996, making the nation TRIPS compliant and expanding its range of patentable products and industries. As a result, the number of patent filings has increased 200% over the last 15 years, without a corresponding increase in PTO examiners. Brazil’s current average waiting time for all technological patents is over 10 years. For pharmaceutical and telecom patents, the average wait time is over 13 years. According to the PTO, the current number of examiners (326) is sufficient to handle the present influx of new filings, however it is the backlog that is keeping the PTO in check. Therefore, the PTO has floated the idea that 231,000 pending patents within the backlog (not including pharma patents, which are covered by a separate regulatory body) be immediately granted with no examination required. Here’s where things get tricky, however: a third party would maintain the right to file a pre-grant opposition within 90 days of the automatic patent filing. Should a pre-grant filing take place, the patent application would automatically be reviewed by the PTO. Companies could then theoretically check the automatic patent application list for competitor patents, and file a pre-grant opposition in order to remove their competitors’ patents from the queue. Of course, that type of action would require an upfront legal spend. Perhaps this is an area that astute litigation funders in the market could pursue– There is additional concern, of course, that patents granted via the automatic waiver may in the long run be vulnerable to invalidity challenges in post-grant opposition, as well as the Federal Courts. Local and state judges may also be reluctant to enforce patent decisions in cases involving patents obtained through automatic application. The PTO itself is not beyond judicial reproach; there have already been numerous lawsuits against the PTO grounded on the unlawfulness of the lengthy backlog, which have successfully compelled the PTO to examine a patent application by means of a court order. So it’s not a given that the PTO’s automatic grant will be accepted by state and even federal courts. Again, these are all nitty-gritty details that could play out in the litigation finance industry’s favor, should the PTO move ahead with its suggested ‘extraordinary solution.’

Commercial

View All
Commercial

Omni Bridgeway Posts Record Q3 FY26 Pipeline as A$391 Million in New Commitments Drives 2.5x Returns

By John Freund |

Omni Bridgeway has reported its Q3 FY26 portfolio update, headlined by an exclusive term sheet pipeline of more than A$600 million — roughly twice the firm's average quarterly pipeline — alongside A$391.8 million in new commitments contracted across 27 investments year-to-date. The Sydney-listed funder, which manages A$5.5 billion in assets across ten funds and operates from more than 20 offices in 15 countries, framed the update as a sign of accelerating deployment and capital formation.

According to GlobeNewswire, the firm has recorded 59 full and partial completions year-to-date, generating A$268.4 million in cash investment proceeds at a 2.5x multiple on invested capital and a 108% fair value conversion ratio. Operating expenses of A$51.2 million remain on track to land below the firm's A$80 million FY26 budget, while management fees of A$27 million are tracking toward an upgraded A$35 million full-year target.

On the capital side, Omni Bridgeway said the full and final close of Funds 4/5 Series II remains on track for FY26, and that more than A$150 million in additional sidecar and overflow capital structures are at advanced diligence stages. The combination of an unusually deep pipeline, strong realizations, and disciplined cost performance positions the funder to defend its narrative of platform scale at a moment when listed peers are under pressure on both fundraising and case-realization timelines.

Commercial

Jonathan Sablone Launches Sablone Advisory LLC, a Boutique Law and Advisory Firm Focused on Litigation Finance

By John Freund |

Jonathan Sablone, a commercial disputes attorney with three decades of cross-border, financial services, and litigation finance experience, has launched Sablone Advisory LLC — a Boston-based boutique positioned to serve claimants, funders, and insurers across the legal finance ecosystem under the tagline "at the intersection of law and finance™."

According to Sablone Advisory LLC, the new firm offers underwriting, diligence, monitoring, and asset management services to litigation funders and to insurers offering contingent risk products. On the claimant side, Sablone Advisory works with plaintiffs and their counsel to position cases for funding, including packaging case portfolios for cross-collateralized funding and insurance wrappers — services that have become increasingly central as funders and insurers structure deals across multiple matters and risk layers.

"I founded Sablone Advisory to assist clients with the most intractable problems and issues facing the legal finance industry," said Sablone in announcing the launch. "'At the intersection of law and finance' is not just a slogan, but a practical, commercial approach to legal problem-solving that I have practiced for decades."

The launch reflects a continuing trend in the litigation finance industry: senior practitioners with capital-markets and complex-litigation backgrounds spinning out of large institutional platforms to offer specialized, independent advisory and underwriting services. As funders increasingly structure portfolio-level deals, layer ATE and contingent risk insurance into capital stacks, and pursue cross-border recoveries, demand for senior independent diligence and asset management — particularly from professionals fluent in both legal strategy and structured finance — has grown.

For claimants and their counsel, the firm's case-positioning services are likely to resonate in a market where funders are increasingly selective about case quality, structure, and counsel pedigree. For funders and insurers, an independent boutique offering monitoring and asset management — separate from origination — represents the kind of service-provider infrastructure that more mature alternative-asset markets typically develop as they scale.

Inquiries can be directed to Jonathan Sablone at jsablone@sabloneadvisory.com or via www.sabloneadvisory.com.

Commercial

Colorado HB 1421 Targets PE and Non-Attorney Funding of Law Firms in Bipartisan Push

By John Freund |

Colorado lawmakers have introduced HB 1421, a bill that would sharply restrict the ability of state law firms to enter financial or contractual arrangements with alternative business structures (ABS) and any entity in which non-attorneys hold ownership stakes or exert direction over legal practice. The bill is notable both for the reach of its restrictions and for the unusual coalition behind it.

As reported by The Sum and Substance, the legislation is sponsored by Democratic Rep. Javier Mabrey of Denver and Republican House Minority Leader Jarvis Caldwell of Monument, with active support from the Colorado Chamber of Commerce and the Colorado Trial Lawyers Association — typically opposing forces in business-litigation policy debates. The bill was scheduled for its first hearing before the House Judiciary Committee on April 29.

HB 1421 would prohibit Colorado law firms from entering arrangements with ABS-style structures relating to legal services, practicing in professional companies where non-lawyers own interests or direct lawyer judgment, or compensating any party where compensation depends on a percentage of legal fees or case recoveries. The bill would also empower courts to halt offending arrangements, order fee reimbursement to clients, and disgorge ABS profits derived from prohibited activities. The article specifically references Burford Capital's litigation funding presence in framing the bill's broader policy concern with non-lawyer financial stakes in legal outcomes.

The legislation lands at a moment when private equity ownership of legal services is expanding rapidly in jurisdictions that permit it — Arizona, Utah, and the District of Columbia — and where PE-backed national platforms are increasingly partnering with firms in non-ABS jurisdictions to extend their operating reach. The Colorado bill, if enacted, would cut against that expansion model by restricting how Colorado firms can collaborate with out-of-state, non-attorney-owned platforms.

For the litigation finance community, the bill is a meaningful data point. Although disclosure-based reform has dominated state-level TPLF debate in 2025-26, HB 1421 reflects a parallel and somewhat different policy thrust: not transparency about funding, but structural limits on the ownership and economic relationships that surround legal practice. The convergence of plaintiffs' bar and chamber-of-commerce support behind a single bill is itself rare, and may presage similar coalitions in other non-ABS states facing PE-driven consolidation pressure.